Exponent Inc
NASDAQ:EXPO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.81
115.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Exponent Inc
Exponent Inc
Income from Continuing Operations
Exponent Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Exponent Inc
NASDAQ:EXPO
|
Income from Continuing Operations
$106.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
TransUnion
NYSE:TRU
|
Income from Continuing Operations
$241.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
33%
|
|
|
Equifax Inc
NYSE:EFX
|
Income from Continuing Operations
$568.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
Leidos Holdings Inc
NYSE:LDOS
|
Income from Continuing Operations
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Verisk Analytics Inc
NASDAQ:VRSK
|
Income from Continuing Operations
$929.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
CoStar Group Inc
NASDAQ:CSGP
|
Income from Continuing Operations
$175.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
15%
|
|
Exponent Inc
Glance View
Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,215 full-time employees. The firm's service offerings are provided on a project-by-project basis. Its segments include Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment is a service group providing technical consulting in different practices primarily in engineering, including biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences and vehicle engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis, including chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences.
See Also
What is Exponent Inc's Income from Continuing Operations?
Income from Continuing Operations
106.3m
USD
Based on the financial report for Sep 29, 2024, Exponent Inc's Income from Continuing Operations amounts to 106.3m USD.
What is Exponent Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
10%
Over the last year, the Income from Continuing Operations growth was 4%. The average annual Income from Continuing Operations growth rates for Exponent Inc have been 1% over the past three years , 6% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
